Please use this identifier to cite or link to this item:
|Title:||The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.|
|Citation:||Ther Adv Urol.2015 Aug;(7)4:167-79|
|Abstract:||To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy.|
|Appears in Collections:||Hospitales > H. U. Infanta Leonor > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.